Market cap
$68,041 Mln
Revenue (TTM)
$20,996 Mln
P/E Ratio
19.6
P/B Ratio
2.8
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | 4.59 | 7.53 | 13.53 | 16.15 | 13.40 |
| EBIT | -7.67 | 12.12 | 24.35 | 33.38 | 37.51 |
| Net Profit | -32.11 | 14.34 | 46.33 | 74.57 | 62.30 |
| EPS | -31.70 | 15.02 | 46.43 | 57.38 | 46.39 |
| Book Value | -- | -- | 10.90 | 9.96 | 8.77 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Dec-25 | Dec-24 |
| EBIT-Margin
| 16.80 | 15.01 | 20.12 | 18.60 | 15.94 |
| Net Margin
| -- | 7.06 | 17.47 | -- | -- |
| Return on equity
| 10.07 | 8.16 | 14.94 | 12.55 | 9.03 |
| Return on Capital
| 6.68 | 5.35 | -- | 8.30 | 6.01 |
| Return on Assets
| 5.55 | 4.42 | 7.45 | 6.95 | 4.98 |
| Debt to Equity (x)
| -- | -- | 0.43 | 0.51 | 0.51 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Boston Scientific Corp (BSX)
|
--
|
8.30
|
6.01
|
5.73
|
2.64
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
14.94
Higher than Peers by 9.97
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Boston Scientific Corp (BSX)
|
14.94
|
12.55
|
9.03
|
8.64
|
4.08
|
|
Peer Median
|
4.98
|
--
|
--
|
--
|
--
|
ROA
7.45
Higher than Peers by 4.98
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Boston Scientific Corp (BSX)
|
7.45
|
6.95
|
4.98
|
4.71
|
2.16
|
|
Peer Median
|
2.47
|
--
|
--
|
--
|
--
|
EBIT Margin
20.12
Higher than Peers by 11.63
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Boston Scientific Corp (BSX)
|
20.12
|
18.60
|
15.94
|
15.85
|
12.66
|
|
Peer Median
|
8.49
|
--
|
--
|
--
|
--
|
Net Margin
17.47
Higher than Peers by 12.71
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Boston Scientific Corp (BSX)
|
17.47
|
14.38
|
11.07
|
11.19
|
5.52
|
|
Peer Median
|
4.75
|
--
|
--
|
--
|
--
|
Cash Profit Margin
--
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Boston Scientific Corp (BSX)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
13.53
Higher than Peers by 4.96
Year on year growth in net sales
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Boston Scientific Corp (BSX)
|
13.53
|
0.20
|
0.18
|
0.12
|
0.07
|
|
Peer Median
|
8.57
|
--
|
--
|
--
|
--
|
EBIT Growth
24.35
Higher than Peers by 13.96
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Boston Scientific Corp (BSX)
|
24.35
|
39.90
|
18.25
|
40.62
|
12.63
|
|
Peer Median
|
10.38
|
--
|
--
|
--
|
--
|
Net Profit Growth
46.33
Higher than Peers by 32.73
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Boston Scientific Corp (BSX)
|
46.33
|
55.66
|
16.38
|
128.22
|
-32.88
|
|
Peer Median
|
13.61
|
--
|
--
|
--
|
--
|
EPS Growth
46.43
Higher than Peers by 25.36
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Boston Scientific Corp (BSX)
|
46.43
|
0.55
|
0.15
|
1.23
|
-0.33
|
|
Peer Median
|
21.08
|
--
|
--
|
--
|
--
|
Book Value Growth
11.83
Higher than Peers by 4.76
Year on year growth in book value per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Boston Scientific Corp (BSX)
|
11.83
|
--
|
--
|
--
|
--
|
|
Peer Median
|
7.07
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
0.43
Higher than Peers by 0.04
Total debt / Net worth
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Boston Scientific Corp (BSX)
|
0.43
|
0.51
|
0.51
|
0.49
|
0.53
|
|
Peer Median
|
0.40
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
0.07
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Boston Scientific Corp (BSX)
|
0.07
|
0.02
|
0.08
|
0.03
|
0.00
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
1.24
Lower than Peers by 1.58
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Boston Scientific Corp (BSX)
|
1.24
|
1.62
|
1.08
|
1.32
|
1.51
|
|
Peer Median
|
2.82
|
--
|
--
|
--
|
--
|
Quick Ratio
0.74
Lower than Peers by 1.31
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Boston Scientific Corp (BSX)
|
0.74
|
1.08
|
0.64
|
0.82
|
1.02
|
|
Peer Median
|
2.04
|
--
|
--
|
--
|
--
|
Interest Coverage
11.64
Higher than Peers by 6.61
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Boston Scientific Corp (BSX)
|
11.64
|
10.70
|
6.90
|
8.30
|
3.46
|
|
Peer Median
|
5.02
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
14.52
Lower than Peers by 1.93
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Boston Scientific Corp (BSX)
|
14.52
|
14.58
|
15.27
|
15.65
|
15.53
|
|
Peer Median
|
16.46
|
--
|
--
|
--
|
--
|
Asset Turnover
0.43
Lower than Peers by 0.08
Sales / Average Total Assets
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Boston Scientific Corp (BSX)
|
0.43
|
0.48
|
0.45
|
0.42
|
0.39
|
|
Peer Median
|
0.50
|
--
|
--
|
--
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Boston Scientific Corp (BSX)
|
--
|
49.89
|
52.19
|
53.84
|
53.97
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Boston Scientific Corp (BSX)
|
--
|
168.92
|
149.20
|
146.90
|
127.82
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Boston Scientific Corp (BSX)
|
--
|
61.77
|
53.60
|
60.91
|
60.88
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Boston Scientific Corp (BSX)
|
--
|
157.04
|
147.79
|
139.83
|
120.91
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
19.56
Lower than Peers by 26.53
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Boston Scientific Corp (BSX)
|
19.56
|
49.42
|
71.79
|
53.60
|
95.62
|
|
Peer Median
|
46.09
|
--
|
--
|
--
|
--
|
Price / Book Value
2.80
Lower than Peers by 1.00
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Boston Scientific Corp (BSX)
|
2.80
|
5.89
|
6.11
|
4.43
|
3.80
|
|
Peer Median
|
3.79
|
--
|
--
|
--
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Boston Scientific Corp (BSX)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
14.50
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Boston Scientific Corp (BSX)
|
14.50
|
29.99
|
36.53
|
27.22
|
27.40
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Market Cap
68,041
Higher than Peers by 67,501
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Boston Scientific Corp (BSX)
|
68,041
|
--
|
--
|
--
|
--
|
|
Peer Median
|
540
|
--
|
--
|
--
|
--
|